Tumoral progression of human breast epithelial cells secreting FGF2 AND FGF4
β Scribed by Boussad Soutton; Chantal Gamby; Michel Crepin; Richard Hamelin
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 839 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The human breast epithelial cell line HBLIOO synthesizes and secretes FGF2, is able to grow in toft agar but is not tumorigenic in nude mice. Transfection of this cell line with the FGF4 gene led to its tumorigenic conversion in a dose-dependent manner as assessed by growth under serum-free conditions, growth in soft agar and growth as xenografts in nude mice. Clones of
Assay for tumorigenicity
Congenitally athymic Swiss nu/nu (nude) mice (Iffa Credo, L'Arbrcsle, France) werc subcutaneously injected with 1 x lo7 cells (104 cells).
π SIMILAR VOLUMES
When FGF-1 or FGF-2 and VEGF were added together, the mitogenic effect of FGF-1 or FGF-2 and VEGF on HUVEC was additive. However, when HUVECs were preincubated for 2 days with 10 ng/ml FGF-1 in the absence of VEGF, the Scatchard plot of [125I]VEGF binding sites was shifted to the right: both affinit
## Abstract Fibroblast growth factor (FGFβ2) and its endogenous antisense RNA FGF antisense (FGFβAS) have been implicated in cancer progression and correlated with clinical outcomes of cancer patients. We previously reported that elevated FGFβAS expression is associated with reduced tumor recurrenc
## Abstract ## Background Overexpression of the fibroblast growth factor __HSTβ1/FGFβ4__ gene is thought to mediate growth properties and malignancy in human testicular germ cell tumors. We have studied the effect that an antisense oligodeoxynucleotide against HSTβ1/FGFβ4 suppresses tumorigenicity